You are here

Humira

AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat

Investors Business Daily

Wed, 10/30/24 - 08:50 pm

Blue Shield of California bypasses PBMs to slash Humira prices by 90%

Pharmaphorum

Wed, 10/2/24 - 09:37 am

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

AOL

Tue, 09/10/24 - 04:33 pm

Unitedhealth Group

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Reuters

Mon, 08/26/24 - 10:14 pm

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth

Fierce Pharma

Fri, 08/9/24 - 11:25 am

GoodRx teams with Boehringer on Humira biosimilar

Axios

Thu, 07/18/24 - 11:21 am

Boehringer Ingelheim

AbbVie’s Humira continues to lose market share as biosimilars gain ground

BioSpace

Fri, 07/12/24 - 11:35 am

AbbVie's tight grip on Humira market raises concerns about biosimilars

Reuters

Fri, 06/7/24 - 11:32 am

The 25 Most Popular Drugs by U.S. Spending

AARP

Fri, 05/10/24 - 11:33 am

prescription spending

Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates

Reuters

Wed, 05/8/24 - 10:58 pm

Teva Pharmaceutical

Sandoz delivers 6% sales growth with Humira biosimilar leading the charge

Fierce Pharma

Tue, 05/7/24 - 06:30 pm

CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered

Forbes

Thu, 05/2/24 - 11:34 am

Drugmaker AbbVie expects Humira volume erosion to worsen

Reuters

Sun, 04/28/24 - 11:18 pm

Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost

BioSpace

Fri, 04/26/24 - 11:09 am

Evernorth Health

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US

BioSpace

Fri, 04/19/24 - 11:28 am

Teva Pharmaceutical

Humira biosimilar scripts take off

Axios

Tue, 04/16/24 - 07:42 am

AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report

BioSpace

Tue, 04/9/24 - 11:15 am

Boehringer to lay off salespeople as Humira biosimilar sales lag

Reuters

Fri, 04/5/24 - 11:33 am

Boehringer Ingelheim

After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge

Fierce Pharma

Sun, 02/25/24 - 08:57 pm

Teva Pharmaceutical

As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B

Fierce Pharma

Fri, 02/2/24 - 11:58 am

Pages